{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:51:40Z","timestamp":1770979900046,"version":"3.50.1"},"reference-count":0,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Clinical Psychopharmacology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/yic.0000000000000029","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T08:14:44Z","timestamp":1390292084000},"page":"212-215","source":"Crossref","is-referenced-by-count":24,"title":["Methylphenidate treatment in children with attention deficit hyperactivity disorder and comorbid social phobia"],"prefix":"10.1097","volume":"29","author":[{"given":"Pavel","family":"Golubchik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sever","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Weizman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","container-title":["International Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YIC.0000000000000029","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:25:20Z","timestamp":1620977120000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.lww.com\/00004850-201407000-00004"}},"subtitle":[""],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":0,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1097\/yic.0000000000000029","relation":{},"ISSN":["0268-1315"],"issn-type":[{"value":"0268-1315","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}